Quiescent phenotype of tumor-specific CD8+ T cells following immunization

被引:59
|
作者
Monsurrò, V
Wang, E
Yamano, Y
Migueles, SA
Panelli, MC
Smith, K
Nagorsen, D
Connors, M
Jacobson, S
Marincola, FM
机构
[1] NIH, Dept Transfus Med, Clin Ctr, Immunogenet Sect, Bethesda, MD 20892 USA
[2] NINDS, Viral Immunol Sect, Neuroimmunol Branch, NIH, Bethesda, MD USA
[3] NIAID, Lab Immunoregulat, NIH, Bethesda, MD USA
关键词
D O I
10.1182/blood-2004-02-0525
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In a human melanoma model of tumor antigen (TA)-based immunization, we tested the functional status of TA-specific CD8(+) cytotoxic T lymphocytes. A "quiescent" phenotype lacking direct ex vivo cytotoxic and proliferative potential was identified that was further characterized by comparing its transcriptional profile to that of TA-specific T cells sensitized in vitro by exposure to the same TA and the T-cell growth factor interleukin 2 (IL-2). Quiescent circulating tumor-specific CD8(+) T cells were deficient in expression of genes associated with T-cell activation, proliferation, and effector function. This quiescent status may explain the observed lack of correlation between the presence of circulating immunization-induced lymphocytes and tumor regression. In addition, the activation of TA-specific T cells by in vitro antigen recall and IL-2 suggests that a complete effector phenotype might be reinstated in vivo to fulfill the potential of anticancer vaccine protocols. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:1970 / 1978
页数:9
相关论文
共 50 条
  • [41] Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells
    Gattinoni, L
    Finkelstein, SE
    Klebanoff, CA
    Antony, PA
    Palmer, DC
    Spiess, PJ
    Hwang, LN
    Yu, ZY
    Wrzesinski, C
    Heimann, DM
    Surh, CD
    Rosenberg, SA
    Restifo, NP
    JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (07): : 907 - 912
  • [42] Phenotype of CD8+ T cells activated in the liver
    Holz, L
    Benseler, V
    Gengos, M
    Newtown, R
    McCaughan, GW
    Bertolino, P
    TISSUE ANTIGENS, 2005, 66 (05): : 444 - 444
  • [43] Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
    Kerkar, Sid P.
    Muranski, Pawel
    Kaiser, Andrew
    Boni, Andrea
    Sanchez-Perez, Luis
    Yu, Zhiya
    Palmer, Douglas C.
    Reger, Robert N.
    Borman, Zachary A.
    Zhang, Ling
    Morgan, Richard A.
    Gattinoni, Luca
    Rosenberg, Steven A.
    Trinchieri, Giorgio
    Restifo, Nicholas P.
    CANCER RESEARCH, 2010, 70 (17) : 6725 - 6734
  • [44] Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP mice
    Bai, Ailin
    Higham, Eileen
    Eisen, Herman N.
    Wittrup, K. Dane
    Chen, Jianzhu
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (35) : 13003 - 13008
  • [45] IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells
    Sun, Zhaojun
    Fourcade, Julien
    Pagliano, Ornella
    Chauvin, Joe-Marc
    Sander, Cindy
    Kirkwood, John M.
    Zarour, Hassane M.
    CANCER RESEARCH, 2015, 75 (08) : 1635 - 1644
  • [46] The apoptosis inhibitor protein survivin induces tumor-specific CD8+ and CD4+ T cells in colorectal cancer patients
    Casati, C
    Dalerba, P
    Rivoltini, L
    Gallino, G
    Deho, P
    Rini, F
    Belli, F
    Mezzanzanica, D
    Costa, A
    Andreola, S
    Leo, E
    Parmiani, G
    Castelli, C
    CANCER RESEARCH, 2003, 63 (15) : 4507 - 4515
  • [47] Immunotherapy of solid tumors utilizing PLGA/Tumor lysate nanoparticles to stimulate TIL and circulating CD8+ tumor-specific T cells
    Hanlon, Douglas
    Cody, Virginia
    Prasad, Shashi
    Saltzman, Mark
    Solbrig, Camille
    CLINICAL IMMUNOLOGY, 2007, 123 : S64 - S64
  • [48] Staining of antigen activated lymphocytes (SAAL):: a highly specific method for flow cytometric quantitation of tumor-specific CD8+ T cells
    Kowalczyk, DW
    Wlazlo, AP
    Giles-Davis, W
    Ertl, HCJ
    JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 241 (1-2) : 131 - 139
  • [49] Immunotherapy of solid tumors utilizing PLGA/tumor lysate nanoparticles to stimulate TIL and circulating CD8+ tumor-specific T cells
    Hanlon, D. J.
    Prasad, S.
    Patriub, V.
    Saltzman, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S55 - S55
  • [50] Distinct myeloid antigen-presenting cells dictate differential fates of tumor-specific CD8+ T cells in pancreatic cancer
    Burrack, Adam L.
    Schmiechen, Zoe C.
    Patterson, Michael T.
    Miller, Ebony A.
    Spartz, Ellen J.
    Rollins, Meagan R.
    Raynor, Jackson F.
    Mitchell, Jason S.
    Kaisho, Tsuneyasu
    Fife, Brian T.
    Stromnes, Ingunn M.
    JCI INSIGHT, 2022, 7 (07)